Amyotrophic lateral sclerosis presenting respiratory failure as the sole initial manifestation.

It is rare that amyotrophic lateral sclerosis (ALS) presents with respiratory failure as the sole initial manifestation. A 72-year-old man with mild c...
581KB Sizes 2 Downloads 6 Views

Recommend Documents

Seven amyotrophic lateral sclerosis patients diagnosed only after development of respiratory failure.
Amyotrophic lateral sclerosis (ALS) is a progressive, neurodegenerative disorder that causes muscle weakness, disability, respiratory failure, and eventually death. However, some ALS patients are diagnosed only after development of respiratory failur

Breathing new life into treatment advances for respiratory failure in amyotrophic lateral sclerosis patients.
In the last three decades, improvements in respiratory management are responsible for increasing survival and improving quality of life for amyotrophic lateral sclerosis (ALS) patients. Nowadays, ALS patients with respiratory involvement are offered

Sleep disorders and respiratory function in amyotrophic lateral sclerosis.
Sleep disorders in amyotrophic lateral sclerosis (ALS) present a significant challenge to the management of patients. Issues include the maintenance of adequate ventilatory status through techniques such as non-invasive ventilation, which has the abi

Respiratory training in an individual with amyotrophic lateral sclerosis.
We examined the impact of expiratory muscle strength training on maximum expiratory pressure, cough spirometry, and disease progression in a 71-year-old male with amyotrophic lateral sclerosis. Maximum expiratory pressure declined 9% over an 8-week s

Respiratory and nutritional support in amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis (ALS) is an uncommon and almost invariably fatal neurodegenerative disease. There is no known cure for ALS, and only one disease-modifying therapy is currently approved. In the absence of robust pharmacologic treatment o

Amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting 20,000 to 30,000 people in the United States. The mainstay of care of patients affected by this disease is supportive and given the multifaceted nature of their

Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis.
Biomarkers for survival in amyotrophic lateral sclerosis (ALS) would facilitate the development of novel drugs. Although respiratory muscle weakness is a known predictor of poor prognosis, a comprehensive comparison of different tests is lacking.

[Neuroinflammation in amyotrophic lateral sclerosis].
Neuroinflammation, characterized by activated astrocytes and microglia, infiltrated T cells, and the subsequent production of inflammatory mediators, is a pathological hallmark of amyotrophic lateral sclerosis (ALS). Since microglia produce proinflam